CN101287846A - 诊断血栓栓塞病和冠心病的方法 - Google Patents

诊断血栓栓塞病和冠心病的方法 Download PDF

Info

Publication number
CN101287846A
CN101287846A CNA2006800376009A CN200680037600A CN101287846A CN 101287846 A CN101287846 A CN 101287846A CN A2006800376009 A CNA2006800376009 A CN A2006800376009A CN 200680037600 A CN200680037600 A CN 200680037600A CN 101287846 A CN101287846 A CN 101287846A
Authority
CN
China
Prior art keywords
egln2
coronary heart
myocardial infarction
heart disease
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2006800376009A
Other languages
English (en)
Chinese (zh)
Inventor
D·科齐安
M·赫尔曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SRL
Original Assignee
Sanofi Aventis SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis SpA filed Critical Sanofi Aventis SpA
Publication of CN101287846A publication Critical patent/CN101287846A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNA2006800376009A 2005-10-12 2006-09-30 诊断血栓栓塞病和冠心病的方法 Pending CN101287846A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005048899.4 2005-10-12
DE102005048899A DE102005048899A1 (de) 2005-10-12 2005-10-12 Verfahren zur Diagnose thromboembolischer Erkrankungen und koronarer Herzerkrankungen

Publications (1)

Publication Number Publication Date
CN101287846A true CN101287846A (zh) 2008-10-15

Family

ID=37684083

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2006800376009A Pending CN101287846A (zh) 2005-10-12 2006-09-30 诊断血栓栓塞病和冠心病的方法

Country Status (14)

Country Link
US (1) US20090197774A1 (https=)
EP (1) EP1937839B1 (https=)
JP (1) JP2009511026A (https=)
KR (1) KR20080052662A (https=)
CN (1) CN101287846A (https=)
AR (1) AR056125A1 (https=)
AT (1) ATE525481T1 (https=)
AU (1) AU2006301578B9 (https=)
BR (1) BRPI0617341A2 (https=)
CA (1) CA2625698A1 (https=)
DE (1) DE102005048899A1 (https=)
IL (1) IL190585A (https=)
TW (1) TW200734638A (https=)
WO (1) WO2007042165A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119846215A (zh) * 2025-01-22 2025-04-18 广西医科大学附属肿瘤医院 Egln1乳酸化作为靶点在制备肿瘤诊断试剂盒或治疗药物中的应用

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005048898A1 (de) * 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
US20100197518A1 (en) 2007-05-01 2010-08-05 Huichun Xu Methods for Diagnosing Ischemia
EP2593566B1 (en) 2010-07-14 2018-01-24 The Regents of The University of California Biomarkers for diagnosis of transient ischemic attacks
US20120065087A1 (en) 2010-07-15 2012-03-15 Regents Of The University Of California Biomarkers for diagnosis of stroke and its causes
US20120316076A1 (en) 2011-03-04 2012-12-13 The Regents Of The University Of California Biomarkers for the diagnosis of lacunar stroke
CN104094121B (zh) * 2011-12-01 2016-10-26 霍夫曼-拉罗奇有限公司 用于诊断中风的nt-原anp和nt-原bnp
US9410204B2 (en) 2012-01-07 2016-08-09 The Regents Of The University Of California Biomarkers for diagnosing ischemia
KR101939778B1 (ko) 2012-07-27 2019-01-18 삼성전자주식회사 필요 혈류량 결정 방법 및 장치, 혈류 영상 생성 방법 및 장치, 심근 관류 영상 처리 방법 및 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1583770A4 (en) * 2002-12-20 2006-10-18 Applera Corp STENOSIS-ASSOCIATED GENETIC POLYMORPHIA, DETECTION METHOD AND ITS USE
CA2941594C (en) * 2002-12-20 2021-07-06 Celera Corporation Genetic polymorphisms of the protein receptor c (procr) associated with myocardial infarction, methods of detection and uses thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119846215A (zh) * 2025-01-22 2025-04-18 广西医科大学附属肿瘤医院 Egln1乳酸化作为靶点在制备肿瘤诊断试剂盒或治疗药物中的应用
CN119846215B (zh) * 2025-01-22 2025-07-11 广西医科大学附属肿瘤医院 Egln1乳酸化作为靶点在制备肿瘤诊断试剂盒或治疗药物中的应用

Also Published As

Publication number Publication date
AU2006301578B2 (en) 2011-12-01
AR056125A1 (es) 2007-09-19
TW200734638A (en) 2007-09-16
DE102005048899A1 (de) 2007-04-19
IL190585A (en) 2011-12-29
BRPI0617341A2 (pt) 2011-07-26
AU2006301578A1 (en) 2007-04-19
IL190585A0 (en) 2008-11-03
US20090197774A1 (en) 2009-08-06
KR20080052662A (ko) 2008-06-11
ATE525481T1 (de) 2011-10-15
JP2009511026A (ja) 2009-03-19
CA2625698A1 (en) 2007-04-19
AU2006301578B9 (en) 2011-12-22
EP1937839A1 (de) 2008-07-02
EP1937839B1 (de) 2011-09-21
WO2007042165A1 (de) 2007-04-19

Similar Documents

Publication Publication Date Title
Rajput et al. Endothelin-1 gene variants and levels associate with adaptation to hypobaric hypoxia in high-altitude natives
IL190585A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
Demokan et al. Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer
KR20020059347A (ko) 인간 ｍｄｒ-1 유전자내 다형 및 진단 및 치료에 있어서그의 용도
KR20110106244A (ko) 간세포암종의 예후 진단용 단일 염기 다형성
CN107217092A (zh) 纤维变性易感性il22ra2基因及其用途
DK2220256T3 (en) An in vitro method for the diagnosis of skin cancer
BRPI0806599A2 (pt) Marcador e plataforma de diagnóstico para elaboração de fármaco em infarto do miocárdio e falência cardíaca
WO2006107031A1 (ja) 遺伝子一塩基多型解析によるアトピー性皮膚炎の相対罹患危険率の検出方法
EP1960543B1 (en) Method for the diagnosis and treatment of cardiovascular diseases
EP2129801B1 (en) Tbc1d1 as a diagnostic marker for obesity or diabetes
HK1125414A (en) Method for diagnosing thromboembolic disorders and coronary heart diseases
CN111154883A (zh) 一种乳腺癌相关基因PIK3CA位点g.179220986A＞T突变体及其应用
US8026063B2 (en) Method of examining inflammatory disease and method of screening remedy for imflammatory disease
JP4348456B2 (ja) グルココルチコイド製剤への感受性の遺伝子診断に用いることができる変異型ポリヌクレオチドおよび核酸分子
JP4444576B2 (ja) ２型糖尿病関連遺伝子
JP3682688B2 (ja) 骨粗鬆症薬剤感受性予測方法およびそのための試薬キット
JP2009022269A (ja) 肥満の検査方法及び肥満の予防又は治療薬のスクリーニング方法
KR100677724B1 (ko) ＨＮＦ-4α 유전자의 단일염기 다형성 및 그 용도
US20140051074A1 (en) Method of judging inflammatory disease by using single nucleotide polymorphism
JP5111763B2 (ja) 気管支喘息の遺伝的素因検査方法
JP3684921B2 (ja) 骨粗鬆症薬剤感受性予測方法
JP2008000096A (ja) 尿路結石症の発症リスク判定方法、及び発症リスク判定用キット
JP4845486B2 (ja) 糖尿病性腎症感受性遺伝子、および糖尿病性腎症の予防または治療剤の有効成分のスクリーニング方法
JP4111482B2 (ja) 循環器疾患の遺伝的要因を判定するための方法及びこれに使用されるオリゴヌクレオチド

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1125414

Country of ref document: HK

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1125414

Country of ref document: HK

C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20081015